Selecting effective antidepressants for the treatment Major Depressive Disorder (MDD) is an imprecise practice, with remission rates of just about 30% at the initial treatment choice. The potential of pharmacogenetic
As research in the burgeoning field of transcranial magnetic stimulation (TMS) continues to expand, new treatment methodologies have continued to emerge. One such approach involves the use of theta burst